Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes’ toxicity

Autor: Che-Hong Chen, Julio C.B. Ferreira, Amit U. Joshi, Matthew C. Stevens, Sin-Jin Li, Jade H.-M. Hsu, Rory Maclean, Nikolas D. Ferreira, Pilar R. Cervantes, Diana D. Martinez, Fernando L. Barrientos, Gibran H.R. Quintanares, Daria Mochly-Rosen
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: EBioMedicine, Vol 55, Iss , Pp - (2020)
Druh dokumentu: article
ISSN: 2352-3964
DOI: 10.1016/j.ebiom.2020.102753
Popis: Background: Aldehyde dehydrogenase 2 (ALDH2) catalyzes the detoxification of aliphatic aldehydes, including acetaldehyde. About 45% of Han Chinese (East Asians), accounting for 8% of humans, carry a single point mutation in ALDH2*2 (E504K) that leads to accumulation of toxic reactive aldehydes. Methods: Sequencing of a small Mexican cohort and a search in the ExAC genomic database for additional ALDH2 variants common in various ethnic groups was set to identify missense variants. These were evaluated in vitro, and in cultured cells expressing these new and common variants. Findings: In a cohort of Hispanic donors, we identified 2 novel mutations in ALDH2. Using the ExAC genomic database, we found these identified variants and at least three other ALDH2 variants with a single point mutation among Latino, African, South Asian, and Finnish ethnic groups, at a frequency of >5/1000. Although located in different parts of the ALDH2 molecule, these common ALDH2 mutants exhibited a significant reduction in activity compared with the wild type enzyme in vitro and in 3T3 cells overexpressing each of the variants, and a greater ethanol-induced toxicity. As Alda-1, previously identified activator, did not activate some of the new mutant ALDH2 enzymes, we continued the screen and identified Alda-64, which is effective in correcting the loss of activity in most of these new and common ALDH2 variants. Interpretation: Since ~80% of the world population consumes ethanol and since acetaldehyde accumulation contributes to a variety of diseases, the identification of additional inactivating variants of ALDH2 in different ethnic groups may help develop new ‘precision medicine’ for carriers of these inactive ALDH2.
Databáze: Directory of Open Access Journals